Abstract:Abstract Background DNA microarrays are rapidly becoming a fundamental tool in discovery-based genomic and biomedical research. However, the reliability of the microarray results is being challenged due to the existence of different technologies and non-standard methods of data analysis and interpretation. In the absence of a "gold standard"/"reference method" for the gene expression measurements, studies evaluating and comparing the performance of various microarray platforms have often yielded subjective and conflicting conclusions. To address this issue we have conducted a large scale TaqMan ® Gene Expression Assay based real-time PCR experiment and used this data set as the reference to evaluate the performance of two representative commercial microarray platforms. Results In this study, we analyzed the gene expression profiles of three human tissues: brain, lung, liver and one universal human reference sample (UHR) using two representative commercial long-oligonucleotide microarray platforms: (1) Applied Biosystems Human Genome Survey Microarrays (based on single-color detection); (2) Agilent Whole Human Genome Oligo Microarrays (based on two-color detection). 1,375 genes represented by both microarray platforms and spanning a wide dynamic range in gene expression levels, were selected for TaqMan ® Gene Expression Assay based real-time PCR validation. For each platform, four technical replicates were performed on the same total RNA samples according to each manufacturer's standard protocols. For Agilent arrays, comparative hybridization was performed using incorporation of Cy5 for brain/lung/liver RNA and Cy3 for UHR RNA (common reference). Using the TaqMan ® Gene Expression Assay based real-time PCR data set as the reference set, the performance of the two microarray platforms was evaluated focusing on the following criteria: (1) Sensitivity and accuracy in detection of expression; (2) Fold change correlation with real-time PCR data in pair-wise tissues as well as in gene expression profiles determined across all tissues; (3) Sensitivity and accuracy in detection of differential expression. Conclusion Our study provides one of the largest "reference" data set of gene expression measurements using TaqMan ® Gene Expression Assay based real-time PCR technology. This data set allowed us to use an alternative gene expression technology to evaluate the performance of different microarray platforms. We conclude that microarrays are indeed invaluable discovery tools with acceptable reliability for genome-wide gene expression screening, though validation of putative changes in gene expression remains advisable. Our study also characterizes the limitations of microarrays; understanding these limitations will enable researchers to more effectively evaluate microarray results in a more cautious and appropriate manner.

A Review of Gene and Isoform Expression Analysis across Multiple Experimental Platforms

Selecting Reliable Mrna Expression Measurements Across Platforms Improves Downstream Analysis

Comparative Performance of the BGISEQ-500 and Illumina HiSeq4000 Sequencing Platforms for Transcriptome Analysis in Plants

Isoform Abundance Inference Provides a More Accurate Estimation of Gene Expression Levels in RNA-seq.

Evaluation and comparison of computational tools for RNA-seq isoform quantification

Evaluation of DNA Microarray Results with Quantitative Gene Expression Platforms

Comprehensive Assessment of Isoform Detection Methods for Third-Generation Sequencing Data

GO-Diff: Mining Functional Differentiation Between EST-based Transcriptomes.

Methods for evaluating gene expression from Affymetrix microarray datasets

A comparison of methods for differential expression analysis of RNA-seq data

A Comparative Analysis of Tissue Gene Expression Data from High-Throughput Studies

Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays

Cross-platform comparison of SYBR ® Green real-time PCR with TaqMan PCR, microarrays and other gene expression measurement technologies evaluated in the MicroArray Quality Control (MAQC) study

DEIsoM: a Hierarchical Bayesian Model for Identifying Differentially Expressed Isoforms Using Biological Replicates

Comprehensive evaluation of differential expression analysis methods for RNA-seq data

A study of inter-lab and inter-platform agreement of DNA microarray data

Cross-platform Performance Evaluation of RNA-Seq and Microarray

Cross-platform comparability of microarray technology: Intra-platform consistency and appropriate data analysis procedures are essential

Union Exon Based Approach for Rna-Seq Gene Quantification: to Be or Not to Be?

Transcriptomics in the RNA-seq era

The Microarray Quality Control (Maqc) Project And Cross-Platform Analysis Of Microarray Data